[Hiring] Post-doctoral Fellow

Job Reference Number: C2I012P2

The Centre for Immunology & Infection (C2I) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.


It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, two major institutions combining their expertise to establish this centre of excellence.


Building on the individual strengths of HKUMed and the Institut Pasteur, the C2I aims to characterise immune responses to infectious agents and their components in a healthy Asian population and develop new vaccine platforms for influenza, new strategies for mosquito-borne viruses and new treatments for lethal respiratory virus infections.



Post-doctoral Fellow (Ref.:C2I012P2)

Applications are now invited for appointment as Post-doctoral Fellow (Ref.:C2I012P2), to commence as soon as possible, on a one-year contract basis with the possibility of renewal subject to satisfactory performance and mutual agreement.

Applicants should possess a Ph.D. degree in biological/medical sciences or a relevant discipline, with at least 4 years of work experience in molecular virology and immunology. Experience in animal work and pathogen-induced immune response will be an advantage. The appointee will work in a research group to conduct influenza vaccine studies.

A highly competitive salary commensurate with qualifications and experience will be offered, in addition to annual leave and medical benefits.

Applicants should submit their up-to-date C.V. and research publication list, quoting the job reference number, current/expected remuneration and availability, through our application platform. Review of applications will start on March 25,2021, and continue until June 30, 2021, or until the post is filled, whichever is earlier. The information provided will be kept confidential and only be used for those purposes relating to your application. We are an equal opportunities employer and welcomes applications from all qualified candidates.


  • LinkedIn
  • Facebook
  • Instagram
  • Twitter